Atria Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$673K Buy
8,517
+607
+8% +$51.6K 0.01% 1357
2026
Q1
$681K Sell
7,910
-538
-6% -$48.3K 0.01% 1284
2025
Q4
$738K Sell
8,448
-1,218
-13% -$92.4K 0.01% 1230
2025
Q3
$554K Sell
9,666
-297
-3% -$17.1K 0.01% 1362
2025
Q2
$588K Buy
9,963
+2,390
+32% +$154K 0.01% 1330
2025
Q1
$554K Sell
7,573
-18
-0.2% -$1.49K 0.01% 1301
2024
Q4
$628K Sell
7,591
-91
-1% -$7.18K 0.01% 1213
2024
Q3
$550K Sell
7,682
-337
-4% -$23.8K 0.01% 1270
2024
Q2
$549K Buy
+8,019
New +$479K 0.01% 1255
2023
Q1
– Sell
-24,347
Closed -$1.81M – 837
2022
Q4
$1.81M Buy
24,347
+6,872
+39% +$468K 0.04% 547
2022
Q3
$1.04M Buy
+17,475
New +$1.05M 0.02% 709

Other funds holding GMED

Atria Investments's GMED Position: Q2 2026 in Review

Atria Investments increased its Globus Medical (GMED) stake by 7.7% in Q2 2026, buying an estimated $51.6K and bringing the position to 8,517 shares worth $673K. The position accounts for 0.01% of the portfolio, ranked #1357.

Atria Investments first reported a position in GMED in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.81M in Q4 2022. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Atria Investments held 8,517 shares of Globus Medical worth $673K as of Q2 2026.
  • Atria Investments bought 607 Globus Medical shares in Q2 2026, an estimated $51.6K.
  • Globus Medical made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1357 holding.
  • Atria Investments first reported a position in Globus Medical in Q3 2022 and has held it in 11 quarters since.
  • Atria Investments's Globus Medical position peaked at $1.81M in Q4 2022.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.